Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 5 | 2023 | 17 | 2.860 |
Why?
|
| Pandemics | 5 | 2023 | 287 | 1.390 |
Why?
|
| Meditation | 2 | 2020 | 17 | 1.300 |
Why?
|
| Mindfulness | 2 | 2020 | 30 | 1.260 |
Why?
|
| Health Status Disparities | 2 | 2021 | 149 | 1.200 |
Why?
|
| Stress, Psychological | 2 | 2020 | 134 | 1.180 |
Why?
|
| Fractures, Bone | 8 | 2019 | 92 | 0.910 |
Why?
|
| Electronic Health Records | 9 | 2023 | 704 | 0.910 |
Why?
|
| Humans | 48 | 2023 | 17314 | 0.900 |
Why?
|
| California | 15 | 2022 | 2311 | 0.840 |
Why?
|
| Middle Aged | 22 | 2021 | 7836 | 0.790 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 202 | 0.770 |
Why?
|
| Hip Fractures | 3 | 2012 | 71 | 0.740 |
Why?
|
| Adult | 18 | 2023 | 7500 | 0.730 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 31 | 0.720 |
Why?
|
| Female | 37 | 2023 | 12396 | 0.720 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 248 | 0.710 |
Why?
|
| Genetic Loci | 1 | 2021 | 54 | 0.700 |
Why?
|
| Neurologists | 1 | 2020 | 2 | 0.700 |
Why?
|
| Intensive Care Units | 1 | 2021 | 99 | 0.680 |
Why?
|
| Yoga | 1 | 2020 | 25 | 0.680 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 372 | 0.660 |
Why?
|
| Aged | 28 | 2021 | 6084 | 0.660 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2023 | 381 | 0.660 |
Why?
|
| Patient Compliance | 2 | 2020 | 277 | 0.640 |
Why?
|
| Patient Selection | 1 | 2020 | 176 | 0.630 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 16 | 0.620 |
Why?
|
| Insurance Coverage | 1 | 2020 | 104 | 0.620 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.620 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.620 |
Why?
|
| Obesity | 4 | 2023 | 814 | 0.610 |
Why?
|
| Poverty | 1 | 2020 | 168 | 0.600 |
Why?
|
| Risk Assessment | 8 | 2020 | 1076 | 0.600 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 100 | 0.600 |
Why?
|
| Community Health Services | 1 | 2019 | 79 | 0.590 |
Why?
|
| Male | 18 | 2023 | 9804 | 0.580 |
Why?
|
| Patient Discharge | 1 | 2019 | 153 | 0.540 |
Why?
|
| Hospitalization | 2 | 2023 | 804 | 0.530 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 302 | 0.520 |
Why?
|
| Mental Disorders | 1 | 2019 | 274 | 0.520 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 245 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 664 | 0.480 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 1280 | 0.470 |
Why?
|
| Primary Health Care | 1 | 2020 | 726 | 0.460 |
Why?
|
| Young Adult | 5 | 2023 | 2465 | 0.450 |
Why?
|
| Cohort Studies | 16 | 2023 | 2514 | 0.430 |
Why?
|
| Telemetry | 1 | 2014 | 2 | 0.430 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 1925 | 0.380 |
Why?
|
| Adolescent | 6 | 2023 | 3538 | 0.370 |
Why?
|
| Osteoporosis | 7 | 2012 | 74 | 0.370 |
Why?
|
| Blood Glucose | 1 | 2014 | 314 | 0.370 |
Why?
|
| Retrospective Studies | 9 | 2023 | 2415 | 0.360 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 69 | 0.340 |
Why?
|
| Bayes Theorem | 1 | 2011 | 72 | 0.340 |
Why?
|
| Telemedicine | 1 | 2014 | 181 | 0.340 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 120 | 0.340 |
Why?
|
| Models, Statistical | 1 | 2011 | 170 | 0.330 |
Why?
|
| Feasibility Studies | 2 | 2020 | 108 | 0.320 |
Why?
|
| Comorbidity | 2 | 2021 | 560 | 0.310 |
Why?
|
| Minority Groups | 2 | 2020 | 104 | 0.310 |
Why?
|
| Sex Factors | 2 | 2021 | 603 | 0.300 |
Why?
|
| Gastrointestinal Agents | 1 | 2008 | 3 | 0.300 |
Why?
|
| Crohn Disease | 1 | 2008 | 12 | 0.300 |
Why?
|
| Treatment Outcome | 4 | 2019 | 1160 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 25 | 0.290 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2021 | 535 | 0.290 |
Why?
|
| Single-Blind Method | 2 | 2019 | 40 | 0.260 |
Why?
|
| Life Style | 5 | 2020 | 316 | 0.260 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 384 | 0.250 |
Why?
|
| Bone Density | 7 | 2012 | 94 | 0.220 |
Why?
|
| Surveys and Questionnaires | 5 | 2022 | 1282 | 0.210 |
Why?
|
| DNA Glycosylases | 1 | 2023 | 5 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2012 | 100 | 0.210 |
Why?
|
| Weight Loss | 3 | 2020 | 294 | 0.200 |
Why?
|
| Dexamethasone | 1 | 2023 | 11 | 0.200 |
Why?
|
| Appendicitis | 1 | 2023 | 14 | 0.200 |
Why?
|
| Health Equity | 1 | 2023 | 22 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 18 | 0.190 |
Why?
|
| Psychotherapy, Psychodynamic | 1 | 2022 | 1 | 0.190 |
Why?
|
| Program Evaluation | 2 | 2019 | 205 | 0.190 |
Why?
|
| Software | 1 | 2021 | 19 | 0.190 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 390 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2020 | 304 | 0.180 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 18 | 0.180 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 33 | 0.180 |
Why?
|
| Hospital Bed Capacity | 1 | 2021 | 5 | 0.180 |
Why?
|
| Health Information Exchange | 1 | 2021 | 3 | 0.180 |
Why?
|
| Medical Informatics | 1 | 2021 | 35 | 0.170 |
Why?
|
| Data Accuracy | 1 | 2021 | 24 | 0.170 |
Why?
|
| Health Policy | 1 | 2021 | 109 | 0.170 |
Why?
|
| Information Dissemination | 1 | 2021 | 50 | 0.170 |
Why?
|
| Logistic Models | 2 | 2019 | 879 | 0.170 |
Why?
|
| Overweight | 2 | 2019 | 266 | 0.170 |
Why?
|
| Asian Americans | 1 | 2021 | 163 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2020 | 202 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2023 | 937 | 0.170 |
Why?
|
| Time Factors | 4 | 2019 | 1039 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 363 | 0.160 |
Why?
|
| Prevalence | 3 | 2020 | 840 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2023 | 282 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2021 | 375 | 0.150 |
Why?
|
| European Continental Ancestry Group | 1 | 2021 | 476 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 605 | 0.150 |
Why?
|
| Weight Reduction Programs | 1 | 2019 | 49 | 0.150 |
Why?
|
| Prediabetic State | 1 | 2019 | 52 | 0.150 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2019 | 61 | 0.150 |
Why?
|
| African Americans | 1 | 2021 | 439 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2019 | 211 | 0.150 |
Why?
|
| Risk Factors | 10 | 2019 | 3258 | 0.150 |
Why?
|
| Age Factors | 2 | 2020 | 878 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2019 | 126 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 437 | 0.140 |
Why?
|
| ROC Curve | 2 | 2019 | 72 | 0.140 |
Why?
|
| Home Care Services | 1 | 2017 | 28 | 0.130 |
Why?
|
| Health Promotion | 1 | 2019 | 279 | 0.130 |
Why?
|
| Terminal Care | 1 | 2017 | 45 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2017 | 72 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 186 | 0.120 |
Why?
|
| Alendronate | 2 | 2006 | 15 | 0.120 |
Why?
|
| United States | 9 | 2023 | 3866 | 0.110 |
Why?
|
| Algorithms | 3 | 2011 | 223 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2014 | 68 | 0.100 |
Why?
|
| Health Status | 2 | 2014 | 293 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2006 | 42 | 0.100 |
Why?
|
| Osteoarthritis | 3 | 1999 | 15 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 203 | 0.100 |
Why?
|
| Cause of Death | 2 | 2012 | 176 | 0.100 |
Why?
|
| Placebo Effect | 1 | 2012 | 7 | 0.100 |
Why?
|
| Relaxation Therapy | 1 | 1992 | 4 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2014 | 275 | 0.090 |
Why?
|
| Headache | 1 | 1992 | 14 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 298 | 0.090 |
Why?
|
| World Health Organization | 1 | 2011 | 10 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2011 | 33 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 146 | 0.090 |
Why?
|
| Drug Utilization | 2 | 2008 | 121 | 0.090 |
Why?
|
| Prognosis | 1 | 2011 | 603 | 0.080 |
Why?
|
| Health Maintenance Organizations | 1 | 2011 | 407 | 0.080 |
Why?
|
| Infliximab | 1 | 2008 | 6 | 0.070 |
Why?
|
| Osteoarthritis, Hip | 3 | 1999 | 8 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2006 | 66 | 0.070 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2008 | 215 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2006 | 18 | 0.060 |
Why?
|
| Child | 2 | 2008 | 2403 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2008 | 805 | 0.060 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 54 | 0.060 |
Why?
|
| Disease Management | 1 | 2006 | 111 | 0.060 |
Why?
|
| Infant | 1 | 2008 | 1161 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2008 | 1380 | 0.050 |
Why?
|
| Extremities | 1 | 2003 | 2 | 0.050 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2003 | 12 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 3 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2023 | 6 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2003 | 30 | 0.050 |
Why?
|
| Oximetry | 1 | 2023 | 2 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 38 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 16 | 0.050 |
Why?
|
| Transcriptome | 1 | 2023 | 25 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2023 | 38 | 0.050 |
Why?
|
| San Francisco | 1 | 2023 | 59 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2006 | 532 | 0.050 |
Why?
|
| Temperature | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 47 | 0.050 |
Why?
|
| Research Report | 1 | 2021 | 23 | 0.050 |
Why?
|
| Professional-Patient Relations | 1 | 2022 | 48 | 0.050 |
Why?
|
| Psychotherapy | 1 | 2022 | 56 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 342 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 76 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 674 | 0.040 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hip Injuries | 1 | 1999 | 3 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 701 | 0.040 |
Why?
|
| Fructosamine | 1 | 1999 | 1 | 0.040 |
Why?
|
| Accidental Falls | 1 | 1999 | 46 | 0.040 |
Why?
|
| Hip | 2 | 1995 | 9 | 0.040 |
Why?
|
| Medicare | 2 | 2017 | 192 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 156 | 0.040 |
Why?
|
| Mortality | 1 | 1999 | 116 | 0.040 |
Why?
|
| Age Distribution | 2 | 2009 | 239 | 0.030 |
Why?
|
| Bone Resorption | 1 | 1997 | 4 | 0.030 |
Why?
|
| Collagen | 1 | 1997 | 8 | 0.030 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2017 | 5 | 0.030 |
Why?
|
| Peptides | 1 | 1997 | 14 | 0.030 |
Why?
|
| Incidence | 2 | 2012 | 1266 | 0.030 |
Why?
|
| Radiography | 4 | 1999 | 36 | 0.030 |
Why?
|
| Aspirin | 1 | 1997 | 63 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 64 | 0.030 |
Why?
|
| Exercise | 1 | 2001 | 515 | 0.030 |
Why?
|
| Finger Joint | 1 | 1995 | 1 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1995 | 139 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 259 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1995 | 22 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1999 | 1151 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1993 | 31 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2012 | 142 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 120 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2006 | 51 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 496 | 0.020 |
Why?
|
| Radius | 3 | 1995 | 3 | 0.020 |
Why?
|
| Calcaneus | 3 | 1995 | 5 | 0.020 |
Why?
|
| Spinal Fractures | 1 | 2009 | 12 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2012 | 235 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 180 | 0.020 |
Why?
|
| Osteoporotic Fractures | 1 | 2009 | 40 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 452 | 0.020 |
Why?
|
| Hand | 2 | 1999 | 3 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2003 | 367 | 0.020 |
Why?
|
| Neoplasms | 1 | 2012 | 446 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 40 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2006 | 82 | 0.020 |
Why?
|
| Hip Joint | 2 | 1996 | 3 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 1999 | 535 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2006 | 56 | 0.010 |
Why?
|
| Lumbar Vertebrae | 2 | 1995 | 19 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 165 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2003 | 71 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2003 | 211 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2003 | 306 | 0.010 |
Why?
|
| Hypertension | 1 | 2006 | 469 | 0.010 |
Why?
|
| Walking | 1 | 2001 | 89 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 81 | 0.010 |
Why?
|
| Health Behavior | 1 | 2001 | 346 | 0.010 |
Why?
|
| Cholesterol | 1 | 1999 | 82 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 1999 | 43 | 0.010 |
Why?
|
| Collagen Type I | 1 | 1997 | 6 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1999 | 1098 | 0.010 |
Why?
|
| Biomarkers | 1 | 1997 | 307 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 969 | 0.010 |
Why?
|
| Femur | 1 | 1995 | 10 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1995 | 231 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1995 | 270 | 0.010 |
Why?
|
| Linear Models | 1 | 1995 | 206 | 0.010 |
Why?
|
| Pain | 1 | 1995 | 75 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1995 | 640 | 0.010 |
Why?
|
| Databases, Bibliographic | 1 | 1993 | 6 | 0.010 |
Why?
|
| Death Certificates | 1 | 1993 | 17 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1993 | 356 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1993 | 1226 | 0.010 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->